AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Jan 6, 2015
29828_dirs_2015-01-06_5fc8c436-1860-469c-981f-4ec63bef834a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-01-02
Reporting Person: Alton Gregg H (EVP, Corp & Med Affairs)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-01-02 | Common Stock | M | 5000 | $19.085 | Acquired | 120694 | Direct |
| 2015-01-02 | Common Stock | S | 4300 | $95.0402 | Disposed | 116394 | Direct |
| 2015-01-02 | Common Stock | S | 700 | $96.0129 | Disposed | 115694 | Direct |
| 2015-01-02 | Common Stock | S | 1799 | $95.0621 | Disposed | 113895 | Direct |
| 2015-01-02 | Common Stock | S | 201 | $95.9891 | Disposed | 113694 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-01-02 | Non-Qualified Stock Option (right to buy) | $19.085 | M | 5000 | Disposed | 2021-01-20 | Common Stock (5000) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3: Sale prices reported for the transactions reported here range from $94.65 to $95.57. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $95.66 to $96.41. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F5: Sale prices reported for the transactions reported here range from $94.70 to $95.67. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F6: Sale prices reported for the transactions reported here range from $95.81 to $96.08. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.